Related Experiment Video

Updated: Aug 17, 2026

Intradermal Inoculation of Mycobacterium avium in the Mouse Ear
09:20

Intradermal Inoculation of Mycobacterium avium in the Mouse Ear

Published on: July 3, 2025

[Three sisters of pulmonary Mycobacterium avium complex disease]

Tetsuro Inoue1, Eisaku Tanaka, Minoru Sakuramoto

  • 1Department of Respiratory Medicine, TENRI Hospital.

Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases
|June 28, 2005
PubMed

Insights

Three sisters with pulmonary Mycobacterium avium complex (MAC) disease showed varied responses to infection. Underlying immune defects, not bacterial strain virulence, likely dictate disease progression in pulmonary MAC.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Immunology

Background:

  • Pulmonary Mycobacterium avium complex (MAC) disease is a significant global health concern.
  • Understanding the pathogenesis of pulmonary MAC is crucial for effective treatment strategies.

Observation:

  • Three sisters presented with pulmonary MAC disease, each infected with different MAC species (M. avium and M. intracellulare).
  • The oldest sister responded well to clarithromycin monotherapy, showing no progression for six years.
  • The second sister showed no disease progression for seven years without treatment.
  • The third sister, with comorbidities, experienced disease progression despite multi-drug chemotherapy and ultimately succumbed to respiratory failure.

Findings:

  • Clinical courses and isolate patterns varied significantly among the sisters.
  • Disease progression appeared independent of the specific MAC isolate or treatment regimen in one case.
  • Autopsy revealed no disseminated MAC disease, suggesting localized pulmonary infection.

Implications:

  • The findings highlight the critical role of host immune status in pulmonary MAC pathogenesis.
  • Underlying anti-mycobacterial immunological impairment and local host defense defects are likely more important than bacterial strain virulence.
  • Further research into host-pathogen interactions and immune responses is warranted for improved therapeutic approaches.

More Related Videos

Identification of Mycobacterium Species by DNA Microarray Chip Method06:27

Identification of Mycobacterium Species by DNA Microarray Chip Method

Published on: June 24, 2025

Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos10:38

Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos

Published on: September 9, 2015

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...